Adrian Heagerty

ORCID: 0000-0003-4351-7467
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Skin and Cellular Biology Research
  • Autoimmune Bullous Skin Diseases
  • Dermatological and Skeletal Disorders
  • Nail Diseases and Treatments
  • Contact Dermatitis and Allergies
  • Glutathione Transferases and Polymorphisms
  • RNA regulation and disease
  • Drug-Induced Adverse Reactions
  • Cell Adhesion Molecules Research
  • Plant Reproductive Biology
  • Skin Protection and Aging
  • Urticaria and Related Conditions
  • Nonmelanoma Skin Cancer Studies
  • melanin and skin pigmentation
  • Eosinophilic Disorders and Syndromes
  • Hair Growth and Disorders
  • Parvovirus B19 Infection Studies
  • Mast cells and histamine
  • Genomics, phytochemicals, and oxidative stress
  • Neonatal skin health care
  • Silk-based biomaterials and applications
  • Wound Healing and Treatments
  • Dermatologic Treatments and Research
  • Dermatology and Skin Diseases
  • Autoimmune and Inflammatory Disorders

University Hospitals Birmingham NHS Foundation Trust
2021-2025

University of Birmingham
2020-2025

NIHR Surgical Reconstruction and Microbiology Research Centre
2024

Solihull Hospital
2001-2023

National Health Service
2023

Heart of England NHS Foundation Trust
2008-2020

Queen Elizabeth Hospital Birmingham
2020

University of Warwick
2017

University of London
2015

Universidad de Londres
2015

LH 7:2 is a monoclonal antibody that was raised against an extract of human epidermal cells and identifies epitope within the lamina densa basement membrane stratified squamous epithelia. Using indirect immunofluorescence we found intense labelling with at (EBM) normal skin, in skin samples from patients simplex, junctional, dominantly inherited dystrophic acquired forms epidermolysis bullosa (EB), as well bullous pemphigoid. Staining absent or only very faint generalized recessive EB...

10.1111/j.1365-2133.1986.tb05707.x article EN British Journal of Dermatology 1986-08-01

Basal cell carcinoma (BCC) is the commonest malignant neoplasm in white people. We present a large UK case-control study which conditional logistic regression analysis of age-matched and gender-matched data sets was used to compare, first, cases with controls (n=403) second, patients having multiple BCC those single (n=278). Eye/hair colour, occupation, skin type, social class, tumour site at presentation smoking history were assessed. Social class 1/2, type 1, red/blonde hair blue/green...

10.1177/014107689709000704 article EN Journal of the Royal Society of Medicine 1997-07-01

The genetic factors that mediate the pathogenesis of multiple primary cutaneous basal cell carcinomas (BCC) are largely unclear. Thus, some patients suffer many BCC (>30) and/or rapid accrual (number tumours/year from first presentation) further lesions. We have studied, in 827 English Caucasians, influence polymorphism carcinogen-metabolizing enzymes on susceptibility to this cancer. Accordingly, we describe, first, a cross-sectional analysis GSTM1, GSTT1, CYP2D6 and CYP1A1 genotypes tumour...

10.1093/carcin/17.9.1891 article EN Carcinogenesis 1996-09-01

AA3 is a novel antibody raised against human amnion, which reacts with the basement membrane of various epithelia ectodermal origin. We use to examine epidermal zone in normal skin and different genetically determined types epidermolysis bullosa (EB), by indirect immunofluorescence. staining was dystrophic simplex EB, but markedly reduced lesional non‐blistered severe forms junctional EB. In non‐lethal intensity variable appeared be inversely associated disease severity, did not correlate...

10.1111/j.1365-2133.1985.tb02400.x article EN British Journal of Dermatology 1985-12-01

The National Health Service (NHS) epidermolysis bullosa (EB) service, established in 2002, offers comprehensive, free care to all patients England and Wales.To quantify prevalence, incidence mortality of EB Wales.Demographic data for Wales were collected on a secure electronic database, prospectively from January 2002 April 2021 retrospectively cases prior 2002. Vital status was verified using central NHS data.By March 2021, 2594 individuals registered, whom 2361 living, which yielded...

10.1111/bjd.20958 article EN British Journal of Dermatology 2021-12-20

Abstract Skin cancer is a global health crisis and leading cause of morbidity mortality worldwide. A factor malignancy remains the UV radiation, driving various biomolecular changes. With shifting population behaviors, deficiency in screening programs reliance on self‐presentation, climate change ageing world populace, incidents have been surging alarmingly. There an urgent need for new technologies to achieve timely intervention through rapid accurate diagnostics skin cancer. Raman...

10.1002/gch2.202400274 article EN cc-by Global Challenges 2025-03-18

<title>Abstract</title> Ablative fractional carbon dioxide (AFCO2) laser therapy is widely used for treating pathological scarring, with promising clinical results. However, mechanisms underlying reduction hypertrophic scarring are poorly understood. We investigated the cellular of AFCO2 by performing single-cell RNA sequencing (scRNA-seq) on skin biopsies from burn survivors scars before and after therapy. Those a good response (GR) to therapy, assessed objectively subjectively, generally...

10.21203/rs.3.rs-5503817/v1 preprint EN cc-by Research Square (Research Square) 2025-03-27

Journal Article Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody Get access A.H.M. HEAGERTY, HEAGERTY Department Electron Microscopy and Cell Pathology, The Institute Dermatology, United Medical Dental Schools, St. Thomas' Hospital, London Search for other works by this author on: Oxford Academic Google Scholar R.A.J. EADY, EADY Dr Eady, Lambeth Palace Road, SE17EH, U.K. A.R. KENNEDY, KENNEDY K.H. NICOLALADES, NICOLALADES Harris Birthright Research...

10.1111/j.1365-2133.1987.tb04132.x article EN British Journal of Dermatology 1987-09-01
Coming Soon ...